Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 253-257

  Koga, Masafumi ^a   Hashimoto, Kunihiko ^b   Murai, Jun ^a   Saito, Hiroshi ^a   Mukai, Mikio ^a   Ikegame, Kazuhiro ^c   Ogawa, Hiroyasu ^c   Kasayama, Soji ^d  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b Aizenbashi Hospital   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Nissay Hospital   (Japan)

Author keywords

Glycated albumin; Glycated hemoglobin; Glycemic control; Hemolytic anemia

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOLYTIC ANEMIA; HEREDITARY ELLIPTOCYTOSIS; HEREDITARY SPHEROCYTOSIS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 78650232702     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.10.014     Document Type: Article

References (31)

1. Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?. J Diabet Complications 1998, 2:214-217.
2. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976, 295:417-420.
3. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978, 20:21-27.
4. Jeffcoate S.L. Diabetes control and complications: the role of glycated haemoglobin, 25years on. Diabet Med 2004, 1:657-665.
5. Bry L., Chen P.C., Sacks D.B. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001, 47:153-163.
6. Panzer S., Kronik G., Lechner K., Bettelheim P., Neumann E., Dudczak R. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 1982, 59:1348-1350.
7. Koga M., Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010, 57:751-762.
8. 1C) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007, 54:139-144.
9. Guthrow C.E., Morris M.A., Day J.F., Thorpe S.R., Baynes J.W. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979, 76:4258-4261.
10. Koga M., Saito H., Mukai M., Matsumoto S., Kasayama S. Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women. Acta Diabetol 2009, 10.1007/s00592-009-0123-6.
11. Koga M., Murai J., Saito H., Matsumoto S., Kasayama S. Usefulness of glycated albumin as a glycemic control marker after iron treatment for diabetic patients with iron deficiency anemia. J Jpn Diab Soc 2009, 52:341-345. [in Japanese].
12. Inaba M., Okuno S., Kumeda Y., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007, 18:896-903.
13. Peacock T.P., Shihabi Z.K., Bleyer A.J., et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008, 7:1062-1068.
14. Hashimoto K., Noguchi S., Morimoto Y., et al. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diab Care 2008, 31:1945-1948.
15. Hashimoto K., Osugi T., Noguchi S., et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diab Care 2010, 33:509-511.
16. Koga M., Matsumoto M., Saito H., Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 2006, 53:387-391.
17. Tominaga M., Makino H., Yoshino G., et al. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005, 42:41-46.
18. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2004, 324:61-71.
19. Kouzuma T., Uemastu Y., Usami T., Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta 2004, 346:135-143.
20. Hashimoto K., Kubo M., Chou M., Nishiki M., Koga M. A case of hereditary spherocytosis with diabetes mellitus and abnormal low level of HbA1c. Med J Kinki Cent Hosp 2001, 22:43-46. [in Japanese].
21. Yoshida N., Miyao M., Kodajima S., Koyama T., Hayashi M., Mizuno Y. A case of type 2 diabetes mellitus with discrepancy between plasma glucose and HbA1c. Diab Front 2002, 13:521-528. [in Japanese].
22. 1c. Diab Care 2002, 25:275-278.
23. Yoshiuchi K., Matsuhisa M., Katakami N., et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008, 55:503-507.
24. Koga M., Otsuki M., Matsumoto S., Saito H., Mukai M., Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta 2007, 378:48-52.
25. Bando Y., Kanehara H., Toya D., Tanaka N., Kasayama S., Koga M. Association of serum glycated albumin to glycated haeglobin A1c ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009, 46:368-372.
26. Panzer S., Graninger W., Kronik G., Bettelheim P., Lechner K. Glycosylated hemoglobin as a long-term parameter in appraising the severity of hemolytic disease. Klin Wochenschr 1983, 61:839-843.
27. Kutter D., Thoma J. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin. Clin Lab 2006, 52:477-481.
28. Koga M., Murai J., Saito H., Matsumoto S., Kasayama S. Effect of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diab Res Clin Pract 2009, 84:163-167.
29. Koga M., Kasayama S., Kanehara H., Bando Y. CLD (chronic liver disease)-HbA1c as a novel indicator for estimation of mean plasma glucose in the patients with chronic liver disease. Diab Res Clin Pract 2008, 81:258-262.
30. Cohen M.P., Clements R.S. Measuring glycated proteins: clinical and methodological aspects. Diab Technol Ther 1999, 1:57-70.
31. Reed P., Bhatnagar D., Dhar H., Winocour P.H. Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidmetry. Clin Chim Acta 1986, 161:191-199.